Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Efficacy of Tenofovir Alafenamide-switching Therapy in Patients With Chronic Hepatitis B Experiencing Clinical Flare-up After Discontinuation of Nucleos[t]Ide Analogues Therapy

NCT04496882 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT04496882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04496882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Efficacy of Tenofovir Alafenamide-switching Therapy in Patients With Chronic Hepatitis B Experiencing Clinical Flare-up After Discontinuation of Nucleos[t]Ide Analogues Therapy
Lead sponsor
National Taiwan University Hospital
Phase
Phase 4
Overall status
Active, not recruiting
Start date
September 9, 2020
Completion date
December 31, 2026
Enrollment
260 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b, hepatitis b reactivation